Physiologic Effects of Continuous Positive Airway Pressure and High Flow Nasal Oxygenation in Patients with Acute Respiratory Distress Syndrome.

Recruiting N/A Interventional Study
Acute Respiratory Distress Syndrome (ARDS) Acute Respiratory Failure with Hypoxia
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 80
Sex
Any
Study type
Interventional
Purpose
Supportive Care
Participants needed
120 (estimated)
Sponsor
Ricard Mellado Artigas · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The acute respiratory distress syndrome (ARDS) consists on a lack of breath due to fluid overload in the lungs that is not produced by a heart desease. Some people with this condition may need to be intubated and connected to invasive mechanical ventilation, but less severe cases may need supplementary oxygen that can be delivered with non-invasive devices, such as CPAP (continuous positive airway…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * PaO2/FiO2 ratio \<300 mmHg with FiO2 \>40% and PEEP ≥5 cmH2O (CPAP) or flow ≥30 L/min (HFNC). * Bilateral pulmonary opacities observed in the chest X-ray, thoracic computerized tomography (CT) scan or lung ultrasonography (bilateral B lines) * \<7 days from the pulmonary insul…
Contacts

Ricard Mellado Artigas, PhD

+34 646217716

rmellado@clinic.cat

CONTACT

Jordi Vallverdú Martínez, MD

+34 622929752

vallverdu@clinic.cat

CONTACT